bluebird bio, Inc.
IL-10 RECEPTOR ALPHA HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
Last updated:
Abstract:
The invention provides improved genome editing compositions and methods for editing an IL-10R.alpha. gene. The invention further provides genome edited cells for the prevention, treatment, or amelioration of at least one symptom of, a cancer, GVHD, a transplant rejection, an infectious disease, an autoimmune disease, an inflammatory disease, or an immunodeficiency.
Status:
Application
Type:
Utility
Filling date:
15 Aug 2017
Issue date:
10 Oct 2019